Test Catalog

Test ID: MTRBM    
MatePair, Targeted Rearrangements, Hematologic, Varies

Useful For Suggests clinical disorders or settings where the test may be helpful

Second-tier testing in hematologic specimens when previous cytogenetic or FISH testing have detected an acquired chromosome abnormality of unknown significance

 

Determining the size, precise breakpoints, gene content, and any unappreciated complexity of abnormalities detected by other methods such as conventional chromosome and FISH studies

 

Providing important diagnostic, prognostic, and therapeutic information critical to proper patient management

Genetics Test Information Provides information that may help with selection of the correct genetic test or proper submission of the test request

This testing is only appropriate in individuals with previously detected acquired chromosomal abnormalities. If previous testing was performed at another institution, supply a copy of those results. If sufficient information regarding the patient's known chromosome abnormality is not made available, this testing will be cancelled.

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

See B-Lymphoblastic Leukemia/Lymphoma Algorithm in Special Instructions

Special Instructions Library of PDFs including pertinent information and forms related to the test

Method Name A short description of the method used to perform the test

Mate-Pair Whole Genome Sequencing

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

MatePair, Targeted, Hematologic

Aliases Lists additional common names for a test, as an aid in searching

Mate-Pair
Mate-Pair sequencing
Mate-Pair analysis
Balanced rearrangement characterization
Acquired translocation characterization
Acquired inversion characterization
Next Gen Sequencing Test
Mate Pair
MatePair